Corporate News Summary – Nexgel, Inc. (NASDAQ: NXGL)
Market Performance
24‑hour trading session (ending 08:55 AM CET, Monday 26 Oct 2026):
Price movement: +5.67 %
Current price: USD 5.03
Volume traded: USD 272.1 k
Shares outstanding: 487.4 k
Market capitalization: USD 2.5 mn
Historical context:
Since last month‑end: -4.01 %
200‑day simple moving average: USD 13.27
52‑week high: USD 53.60 (11 Jun 2025)
52‑week low: USD 3.00 (10 Aug 2026)
Peer Activity (24‑hour snapshot)
| Symbol | Last 24 h change | Current price (USD) | Market cap (USD mn) |
|---|---|---|---|
| Vivos Therapeutics (VVOS) | +0.75 % | 0.13 | 2.7 |
| Aptevo Therapeutics (APVO) | 0.00 % | 1.61 | 2.9 |
| Mustang Bio (MBIO) | +0.27 % | 0.37 | 2.8 |
| Interactive Strength (TRNR) | -2.26 % | 1.73 | 2.8 |
| Bluejay Diagnostics (BJDX) | -7.00 % | 0.58 | 2.6 |
Company Overview
Nexgel, Inc. is headquartered in Langhorne, United States, and specializes in hydrogel solutions. The company produces high‑water‑content, electron‑beam cross‑linked aqueous polymer hydrogels used in over‑the‑counter medications, wound‑healing products, cosmetics, and commercial applications.
Prepared on 26 Oct 2026. No additional commentary or speculation is included.